| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |